☰

Sangeeta Joshi, Ph.D. - Publications

Affiliations: 
2012 Pathology Wayne State University, Detroit, MI, United States 
Area:
Pathology

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Dilly AK, Tang K, Guo Y, Joshi S, Ekambaram P, Maddipati KR, Cai Y, Tucker SC, Honn KV. Convergence of Eicosanoid and Integrin Biology: Role of Src in 12-LOX activation. Experimental Cell Research. PMID 28011194 DOI: 10.1016/j.yexcr.2016.12.011  0.44
2016 Arora J, Hu Y, Esfandiary R, Sathish HA, Bishop SM, Joshi SB, Middaugh CR, Volkin DB, Weis DD. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity. Mabs. 0. PMID 27560842 DOI: 10.1080/19420862.2016.1222342  0.44
2016 Toprani VM, Joshi SB, Kueltzo LA, Schwartz RM, Middaugh CR, Volkin DB. A Micro-Polyethylene Glycol Precipitation Assay as a Relative Solubility Screening Tool for Monoclonal Antibody Design and Formulation Development. Journal of Pharmaceutical Sciences. PMID 27368120 DOI: 10.1016/j.xphs.2016.05.021  0.44
2016 Hickey JM, Sahni N, Toth RT, Kumru OS, Joshi SB, Middaugh CR, Volkin DB. Challenges and opportunities of using liquid chromatography and mass spectrometry methods to develop complex vaccine antigens as pharmaceutical dosage forms. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. PMID 27071526 DOI: 10.1016/j.jchromb.2016.04.001  0.44
2016 Wahome N, Sully E, Singer C, Thomas JC, Hu L, Joshi SB, Volkin DB, Fang J, Karanicolas J, Jacobs DJ, Mantis NJ, Middaugh CR. Novel Ricin Subunit Antigens With Enhanced Capacity to Elicit Toxin-Neutralizing Antibody Responses in Mice. Journal of Pharmaceutical Sciences. PMID 26987947 DOI: 10.1016/j.xphs.2016.02.009  0.44
2016 Mozziconacci O, Arora J, Toth Iv RT, Joshi SB, Zhou S, Volkin DB, Schoneich C. Site-specific hydrolysis reaction C-terminal of methionine in Met-His during metal-catalyzed oxidation of IgG-1. Molecular Pharmaceutics. PMID 26942274 DOI: 10.1021/acs.molpharmaceut.5b00944  0.44
2016 Kim JH, Joshi SB, Esfandiary R, Iyer V, Bishop SM, Volkin DB, Middaugh CR. Improved Comparative Signature Diagrams to Evaluate Similarity of Storage Stability Profiles of Different IgG1 mAbs. Journal of Pharmaceutical Sciences. PMID 26886311 DOI: 10.1016/j.xphs.2016.01.008  0.44
2016 Kim JH, Joshi SB, Tolbert TJ, Middaugh CR, Volkin DB, Smalter Hall A. Biosimilarity Assessments of Model IgG1-Fc Glycoforms Using a Machine Learning Approach. Journal of Pharmaceutical Sciences. 105: 602-12. PMID 26869422 DOI: 10.1016/j.xphs.2015.10.013  0.44
2016 More AS, Toprani VM, Okbazghi SZ, Kim JH, Joshi SB, Middaugh CR, Tolbert TJ, Volkin DB. Correlating the Impact of Well-Defined Oligosaccharide Structures on Physical Stability Profiles of IgG1-Fc Glycoforms. Journal of Pharmaceutical Sciences. 105: 588-601. PMID 26869421 DOI: 10.1016/j.xphs.2015.10.014  0.44
2016 Okbazghi SZ, More AS, White DR, Duan S, Shah IS, Joshi SB, Middaugh CR, Volkin DB, Tolbert TJ. Production, Characterization, and Biological Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilarity Analysis. Journal of Pharmaceutical Sciences. 105: 559-74. PMID 26869419 DOI: 10.1016/j.xphs.2015.11.003  0.44
2015 Tang K, Cai Y, Joshi S, Tovar E, Tucker SC, Maddipati KR, Crissman JD, Repaskey WT, Honn KV. Convergence of eicosanoid and integrin biology: 12-lipoxygenase seeks a partner. Molecular Cancer. 14: 111. PMID 26037302 DOI: 10.1186/s12943-015-0382-5  0.44
2015 Hassett KJ, Vance DJ, Jain NK, Sahni N, Rabia LA, Cousins MC, Joshi S, Volkin DB, Middaugh CR, Mantis NJ, Carpenter JF, Randolph TW. Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants. Journal of Pharmaceutical Sciences. 104: 627-39. PMID 25581103 DOI: 10.1002/jps.24295  0.44
2015 Telikepalli S, Kumru OS, Kim JH, Joshi SB, O'Berry KB, Blake-Haskins AW, Perkins MD, Middaugh CR, Volkin DB. Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stress. Journal of Pharmaceutical Sciences. 104: 495-507. PMID 25522000 DOI: 10.1002/jps.24242  0.44
2015 Chen X, Choudhari SP, Martinez-Becerra FJ, Kim JH, Dickenson NE, Toth RT, Joshi SB, Greenwood JC, Clements JD, Picking WD, Middaugh CR, Picking WL. Impact of detergent on biophysical properties and immune response of the IpaDB fusion protein, a candidate subunit vaccine against Shigella species. Infection and Immunity. 83: 292-9. PMID 25368115 DOI: 10.1128/IAI.02457-14  0.44
2015 Kumru OS, Joshi SB, Thapa P, Pheasey N, Bullock PS, Bashiri H, Siska CS, Kerwin BA, He F, Volkin DB, Middaugh CR. Characterization of an oncolytic herpes simplex virus drug candidate. Journal of Pharmaceutical Sciences. 104: 485-94. PMID 25362835 DOI: 10.1002/jps.24211  0.44
2015 Choudhari SP, Chen X, Kim JH, Van Roosmalen ML, Greenwood JC, Joshi SB, Picking WD, Leenhouts K, Middaugh CR, Picking WL. Biophysical characterization of the type III secretion tip proteins and the tip proteins attached to bacterium-like particles. Journal of Pharmaceutical Sciences. 104: 424-32. PMID 24916512 DOI: 10.1002/jps.24047  0.44
2014 Jain NK, Sahni N, Kumru OS, Joshi SB, Volkin DB, Russell Middaugh C. Formulation and stabilization of recombinant protein based virus-like particle vaccines. Advanced Drug Delivery Reviews. PMID 25451136 DOI: 10.1016/j.addr.2014.10.023  0.44
2014 Naik S, Kumru OS, Cullom M, Telikepalli SN, Lindboe E, Roop TL, Joshi SB, Amin D, Gao P, Middaugh CR, Volkin DB, Fisher MT. Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometry. Protein Science : a Publication of the Protein Society. 23: 1461-78. PMID 25043635 DOI: 10.1002/pro.2515  0.44
2014 Kumru OS, Joshi SB, Smith DE, Middaugh CR, Prusik T, Volkin DB. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies. Biologicals : Journal of the International Association of Biological Standardization. 42: 237-59. PMID 24996452 DOI: 10.1016/j.biologicals.2014.05.007  0.44
2014 Alsenaidy MA, Okbazghi SZ, Kim JH, Joshi SB, Middaugh CR, Tolbert TJ, Volkin DB. Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp/Gln residues at site Asn 297. Journal of Pharmaceutical Sciences. 103: 1613-27. PMID 24740840 DOI: 10.1002/jps.23975  0.44
2014 Telikepalli SN, Kumru OS, Kalonia C, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions. Journal of Pharmaceutical Sciences. 103: 796-809. PMID 24452866 DOI: 10.1002/jps.23839  0.44
2014 Hickey JM, Holtz KM, Manikwar P, Joshi SB, McPherson CE, Buckland B, Srivastava IK, Middaugh CR, Volkin DB. Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage. Journal of Pharmaceutical Sciences. 103: 821-7. PMID 24425059 DOI: 10.1002/jps.23848  0.44
2014 Maddux NR, Iyer V, Cheng W, Youssef AM, Joshi SB, Volkin DB, Ralston JP, Winter G, Middaugh CR. High throughput prediction of the long-term stability of pharmaceutical macromolecules from short-term multi-instrument spectroscopic data. Journal of Pharmaceutical Sciences. 103: 828-39. PMID 24421157 DOI: 10.1002/jps.23849  0.44
2014 Khasa H, Kramer R, Maddux N, Hamborg M, Joshi SB, Volkin DB, Middaugh CR. Studies of the aggregation of RNase Sa. Journal of Pharmaceutical Sciences. 103: 395-9. PMID 24382748 DOI: 10.1002/jps.23841  0.44
2013 Cheng W, Joshi SB, Jain NK, He F, Kerwin BA, Volkin DB, Middaugh CR. Linking the solution viscosity of an IgG2 monoclonal antibody to its structure as a function of pH and temperature. Journal of Pharmaceutical Sciences. 102: 4291-304. PMID 24142544 DOI: 10.1002/jps.23748  0.44
2013 Kramer RM, Zeng Y, Sahni N, Kueltzo LA, Schwartz RM, Srivastava IK, Crane L, Joshi SB, Volkin DB, Middaugh CR. Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions. Journal of Pharmaceutical Sciences. 102: 4305-14. PMID 24129946 DOI: 10.1002/jps.23749  0.44
2013 Alsenaidy MA, Kim JH, Majumdar R, Weis DD, Joshi SB, Tolbert TJ, Middaugh CR, Volkin DB. High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation. Journal of Pharmaceutical Sciences. 102: 3942-56. PMID 24114789 DOI: 10.1002/jps.23730  0.44
2013 Iyer V, Hu L, Schanté CE, Vance D, Chadwick C, Jain NK, Brey RN, Joshi SB, Volkin DB, Andra KK, Bann JG, Mantis NJ, Middaugh CR. Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine. Human Vaccines & Immunotherapeutics. 9: 2362-70. PMID 23925275 DOI: 10.4161/hv.25852  0.44
2013 Thakkar SV, Sahni N, Joshi SB, Kerwin BA, He F, Volkin DB, Middaugh CR. Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies. Protein Science : a Publication of the Protein Society. 22: 1295-305. PMID 23893936 DOI: 10.1002/pro.2316  0.44
2013 Cheng W, Curti E, Rezende WC, Kwityn C, Zhan B, Gillespie P, Plieskatt J, Joshi SB, Volkin DB, Hotez PJ, Middaugh CR, Bottazzi ME. Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis. Human Vaccines & Immunotherapeutics. 9: 2351-61. PMID 23880663 DOI: 10.4161/hv.25788  0.44
2013 Wang T, Kumru OS, Yi L, Wang YJ, Zhang J, Kim JH, Joshi SB, Middaugh CR, Volkin DB. Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment. Journal of Pharmaceutical Sciences. 102: 2520-37. PMID 23824562 DOI: 10.1002/jps.23645  0.44
2013 Martinez-Becerra FJ, Scobey M, Harrison K, Choudhari SP, Quick AM, Joshi SB, Middaugh CR, Picking WL. Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella. Vaccine. 31: 2667-72. PMID 23602665 DOI: 10.1016/j.vaccine.2013.04.012  0.44
2013 Thomas JC, O'Hara JM, Hu L, Gao FP, Joshi SB, Volkin DB, Brey RN, Fang J, Karanicolas J, Mantis NJ, Middaugh CR. Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen. Human Vaccines & Immunotherapeutics. 9: 744-52. PMID 23563512 DOI: 10.4161/hv.22998  0.44
2013 Choudhari SP, Kramer R, Barta ML, Greenwood JC, Geisbrecht BV, Joshi SB, Picking WD, Middaugh CR, Picking WL. Studies of the conformational stability of invasion plasmid antigen B from Shigella. Protein Science : a Publication of the Protein Society. 22: 666-70. PMID 23494968 DOI: 10.1002/pro.2249  0.44
2013 Dickenson NE, Choudhari SP, Adam PR, Kramer RM, Joshi SB, Middaugh CR, Picking WL, Picking WD. Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon. Protein Science : a Publication of the Protein Society. 22: 614-27. PMID 23456854 DOI: 10.1002/pro.2245  0.44
2013 Hu L, Joshi SB, Liyanage MR, Pansalawatta M, Alderson MR, Tate A, Robertson G, Maisonneuve J, Volkin DB, Middaugh CR. Physical characterization and formulation development of a recombinant pneumolysoid protein-based pneumococcal vaccine. Journal of Pharmaceutical Sciences. 102: 387-400. PMID 23161162 DOI: 10.1002/jps.23375  0.44
2013 Iyer V, Maddux N, Hu L, Cheng W, Youssef AK, Winter G, Joshi SB, Volkin DB, Middaugh CR. Comparative signature diagrams to evaluate biophysical data for differences in protein structure across various formulations. Journal of Pharmaceutical Sciences. 102: 43-51. PMID 23160989 DOI: 10.1002/jps.23367  0.44
2013 Liu J, Blasie CA, Shi S, Joshi SB, Middaugh CR, Volkin DB. Characterization and stabilization of recombinant human protein pentraxin (rhPTX-2). Journal of Pharmaceutical Sciences. 102: 827-41. PMID 23160921 DOI: 10.1002/jps.23360  0.44
2013 Xiao Y, Zeng Y, Alexander E, Mehta S, Joshi SB, Buchman GW, Volkin DB, Middaugh CR, Isaacs SN. Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge. Vaccine. 31: 319-26. PMID 23153450 DOI: 10.1016/j.vaccine.2012.11.007  0.44
2012 Thakkar SV, Kim JH, Samra HS, Sathish HA, Bishop SM, Joshi SB, Volkin DB, Middaugh CR. Local dynamics and their alteration by excipients modulate the global conformational stability of an lgG1 monoclonal antibody. Journal of Pharmaceutical Sciences. 101: 4444-57. PMID 23060088 DOI: 10.1002/jps.23332  0.44
2012 Hu L, Joshi SB, Andra KK, Thakkar SV, Volkin DB, Bann JG, Middaugh CR. Comparison of the structural stability and dynamic properties of recombinant anthrax protective antigen and its 2-fluorohistidine-labeled analogue. Journal of Pharmaceutical Sciences. 101: 4118-28. PMID 22911632 DOI: 10.1002/jps.23294  0.44
2012 Kim JH, Iyer V, Joshi SB, Volkin DB, Middaugh CR. Improved data visualization techniques for analyzing macromolecule structural changes. Protein Science : a Publication of the Protein Society. 21: 1540-53. PMID 22898970 DOI: 10.1002/pro.2144  0.44
2012 Kumru OS, Liu J, Ji JA, Cheng W, Wang YJ, Wang T, Joshi SB, Middaugh CR, Volkin DB. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags. Journal of Pharmaceutical Sciences. 101: 3636-50. PMID 22733600 DOI: 10.1002/jps.23224  0.44
2012 Thakkar SV, Allegre KM, Joshi SB, Volkin DB, Middaugh CR. An application of ultraviolet spectroscopy to study interactions in proteins solutions at high concentrations. Journal of Pharmaceutical Sciences. 101: 3051-61. PMID 22581726 DOI: 10.1002/jps.23188  0.44
2012 Thakkar SV, Joshi SB, Jones ME, Sathish HA, Bishop SM, Volkin DB, Middaugh CR. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies. Journal of Pharmaceutical Sciences. 101: 3062-77. PMID 22581714 DOI: 10.1002/jps.23187  0.44
2012 Iyer V, Hu L, Liyanage MR, Esfandiary R, Reinisch C, Meinke A, Maisonneuve J, Volkin DB, Joshi SB, Middaugh CR. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae. Journal of Pharmaceutical Sciences. 101: 3078-90. PMID 22538529 DOI: 10.1002/jps.23175  0.44
2012 Plieskatt JL, Rezende WC, Olsen CM, Trefethen JM, Joshi SB, Middaugh CR, Hotez PJ, Bottazzi ME. Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies. Human Vaccines & Immunotherapeutics. 8: 765-76. PMID 22495115 DOI: 10.4161/hv.19726  0.44
2012 Shi S, Liu J, Joshi SB, Krasnoperov V, Gill P, Middaugh CR, Volkin DB. Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA. Journal of Pharmaceutical Sciences. 101: 1969-84. PMID 22411527 DOI: 10.1002/jps.23096  0.44
2012 Iyer V, Liyanage MR, Shoji Y, Chichester JA, Jones RM, Yusibov V, Joshi SB, Middaugh CR. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen. Human Vaccines & Immunotherapeutics. 8: 453-64. PMID 22370514 DOI: 10.4161/hv.19106  0.44
2012 Cheng W, Joshi SB, He F, Brems DN, He B, Kerwin BA, Volkin DB, Middaugh CR. Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements. Journal of Pharmaceutical Sciences. 101: 1701-20. PMID 22323186 DOI: 10.1002/jps.23076  0.44
2012 Bhambhani A, Kissmann JM, Joshi SB, Volkin DB, Kashi RS, Middaugh CR. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions. Journal of Pharmaceutical Sciences. 101: 1120-35. PMID 22147527 DOI: 10.1002/jps.23008  0.44
2011 Hu L, Olsen C, Maddux N, Joshi SB, Volkin DB, Middaugh CR. Investigation of protein conformational stability employing a multimodal spectrometer. Analytical Chemistry. 83: 9399-405. PMID 22047496 DOI: 10.1021/ac201995c  0.44
2011 Hu L, Trefethen JM, Zeng Y, Yee L, Ohtake S, Lechuga-Ballesteros D, Warfield KL, Aman MJ, Shulenin S, Unfer R, Enterlein SG, Truong-Le V, Volkin DB, Joshi SB, Middaugh CR. Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles. Journal of Pharmaceutical Sciences. 100: 5156-73. PMID 21858822 DOI: 10.1002/jps.22724  0.44
2011 Kamerzell TJ, Esfandiary R, Joshi SB, Middaugh CR, Volkin DB. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. Advanced Drug Delivery Reviews. 63: 1118-59. PMID 21855584 DOI: 10.1016/j.addr.2011.07.006  0.44
2011 Guo Y, Zhang W, Giroux C, Cai Y, Ekambaram P, Dilly AK, Hsu A, Zhou S, Maddipati KR, Liu J, Joshi S, Tucker SC, Lee MJ, Honn KV. Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. The Journal of Biological Chemistry. 286: 33832-40. PMID 21712392 DOI: 10.1074/jbc.M110.216564  0.44
2011 Maddux NR, Joshi SB, Volkin DB, Ralston JP, Middaugh CR. Multidimensional methods for the formulation of biopharmaceuticals and vaccines. Journal of Pharmaceutical Sciences. 100: 4171-97. PMID 21647886 DOI: 10.1002/jps.22618  0.44
2011 Zeng Y, Ramsey JD, King R, Leviten M, Mcguire R, Volkin DB, Joshi SB, Middaugh CR. Identifying stabilizers of plasmid DNA for pharmaceutical use. Journal of Pharmaceutical Sciences. 100: 904-14. PMID 20740679 DOI: 10.1002/jps.22330  0.44
2011 Kissmann J, Joshi SB, Haynes JR, Dokken L, Richardson C, Middaugh CR. H1N1 influenza virus-like particles: physical degradation pathways and identification of stabilizers. Journal of Pharmaceutical Sciences. 100: 634-45. PMID 20669328 DOI: 10.1002/jps.22304  0.44
2010 Markham AP, Barrett BS, Esfandiary R, Picking WL, Picking WD, Joshi SB, Middaugh CR. Formulation and immunogenicity of a potential multivalent type III secretion system-based protein vaccine. Journal of Pharmaceutical Sciences. 99: 4497-509. PMID 20845449 DOI: 10.1002/jps.22195  0.44
2010 Barrett BS, Markham AP, Esfandiary R, Picking WL, Picking WD, Joshi SB, Middaugh CR. Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidates. Journal of Pharmaceutical Sciences. 99: 4488-96. PMID 20845448 DOI: 10.1002/jps.22180  0.44
2010 Esfandiary R, Yee L, Ohtake S, Martin RA, Truong-Le VL, Lechuga-Ballesteros D, Moore DS, Joshi SB, Middaugh CR. Biophysical characterization of rotavirus serotypes G1, G3 and G4. Human Vaccines. 6: 390-8. PMID 20534978  0.44
2010 Samra HS, He F, Bhambhani A, Pipkin JD, Zimmerer R, Joshi SB, Middaugh CR. The effects of substituted cyclodextrins on the colloidal and conformational stability of selected proteins. Journal of Pharmaceutical Sciences. 99: 2800-18. PMID 20049940 DOI: 10.1002/jps.22053  0.44
2010 He F, Joshi SB, Moore DS, Shinogle HE, Ohtake S, Lechuga-Ballesteros D, Martin RA, Truong-Le VL, Middaugh CR. Using spectroscopic and microscopic methods to probe the structural stability of human adenovirus type 4. Human Vaccines. 6: 202-11. PMID 19946219 DOI: 10.4161/hv.6.2.10254  0.44
2009 Esfandiary R, Hunjan JS, Lushington GH, Joshi SB, Middaugh CR. Temperature dependent 2nd derivative absorbance spectroscopy of aromatic amino acids as a probe of protein dynamics. Protein Science : a Publication of the Protein Society. 18: 2603-14. PMID 19827094 DOI: 10.1002/pro.264  0.44
2009 Cai S, He F, Samra HS, de la Maza LM, Bottazzi ME, Joshi SB, Middaugh CR. Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. Molecular Pharmaceutics. 6: 1553-61. PMID 19650664 DOI: 10.1021/mp900110q  0.44
2009 Zeng Y, Fan H, Chiueh G, Pham B, Martin R, Lechuga-Ballesteros D, Truong VL, Joshi SB, Middaugh CR. Towards development of stable formulations of a live attenuated bacterial vaccine: a preformulation study facilitated by a biophysical approach. Human Vaccines. 5: 322-31. PMID 19221516 DOI: 10.4161/hv.5.5.7559  0.44
2009 He F, Joshi SB, Bosman F, Verhaeghe M, Middaugh CR. Structural stability of hepatitis C virus envelope glycoprotein E1: effect of pH and dissociative detergents. Journal of Pharmaceutical Sciences. 98: 3340-57. PMID 19072857 DOI: 10.1002/jps.21657  0.44
2009 Esfandiary R, Kickhoefer VA, Rome LH, Joshi SB, Middaugh CR. Structural stability of vault particles. Journal of Pharmaceutical Sciences. 98: 1376-86. PMID 18683860 DOI: 10.1002/jps.21508  0.44
2008 Ausar SF, Joshi SB, Middaugh CR. Spectroscopic methods for the physical characterization and formulation of nonviral gene delivery systems Methods in Molecular Biology (Clifton, N.J.). 434: 55-80. PMID 18470639 DOI: 10.1007/978-1-60327-248-3_5  0.44
2008 Brooks AE, Stricker SM, Joshi SB, Kamerzell TJ, Middaugh CR, Lewis RV. Properties of synthetic spider silk fibers based on Argiope aurantia MaSp2. Biomacromolecules. 9: 1506-10. PMID 18457450 DOI: 10.1021/bm701124p  0.44
2008 Kissmann J, Ausar SF, Rudolph A, Braun C, Cape SP, Sievers RE, Federspiel MJ, Joshi SB, Middaugh CR. Stabilization of measles virus for vaccine formulation. Human Vaccines. 4: 350-9. PMID 18382143  0.44
2008 Salnikova MS, Joshi SB, Rytting JH, Warny M, Middaugh CR. Physical characterization of Clostridium difficile toxins and toxoids: effect of the formaldehyde crosslinking on thermal stability Journal of Pharmaceutical Sciences. 97: 3735-3752. PMID 18257030 DOI: 10.1002/jps.21261  0.44
2008 Salnikova MS, Joshi SB, Rytting JH, Warny M, Middaugh CR. Preformulation studies of Clostridium difficile toxoids A and B Journal of Pharmaceutical Sciences. 97: 4194-4207. PMID 18228584 DOI: 10.1002/jps.21300  0.44
2007 Brandau DT, Joshi SB, Smalter AM, Kim S, Steadman B, Middaugh CR. Stability of the Clostridium botulinum type A neurotoxin complex: an empirical phase diagram based approach. Molecular Pharmaceutics. 4: 571-82. PMID 17552543 DOI: 10.1021/mp0601244  0.44
2006 Lucas LH, Ersoy BA, Kueltzo LA, Joshi SB, Brandau DT, Thyagarajapuram N, Peek LJ, Middaugh CR. Probing protein structure and dynamics by second-derivative ultraviolet absorption analysis of cation-{pi} interactions. Protein Science : a Publication of the Protein Society. 15: 2228-43. PMID 16963649 DOI: 10.1110/ps.062133706  0.44
2006 Peek LJ, Brandau DT, Jones LS, Joshi SB, Middaugh CR. A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine. Vaccine. 24: 5839-51. PMID 16735084 DOI: 10.1016/j.vaccine.2006.04.067  0.44
2006 Jiang G, Joshi SB, Peek LJ, Brandau DT, Huang J, Ferriter MS, Woodley WD, Ford BM, Mar KD, Mikszta JA, Hwang CR, Ulrich R, Harvey NG, Middaugh CR, Sullivan VJ. Anthrax vaccine powder formulations for nasal mucosal delivery. Journal of Pharmaceutical Sciences. 95: 80-96. PMID 16315230 DOI: 10.1002/jps.20484  0.44
Show low-probability matches.